Literature DB >> 34116718

Screening and identification of Theileria annulata subtelomere-encoded variable secreted protein-950454 (SVSP454) interacting proteins from bovine B cells.

Zhi Li1, Junlong Liu2, Quanying Ma1, Aihong Liu1, Youquan Li1, Guiquan Guan1, Jianxun Luo1, Hong Yin3,4.   

Abstract

BACKGROUND: Theileria annulata is a protozoan parasite that can infect and transform bovine B cells, macrophages, and dendritic cells. The mechanism of the transformation is still not well understood, and some parasite molecules have been identified, which contribute to cell proliferation by regulating host signaling pathways. Subtelomeric variable secreted proteins (SVSPs) of Theileria might affect the host cell phenotype, but its function is still not clear. Therefore, in the present study, we explored the interactions of SVSP454 with host cell proteins to investigate the molecular mechanism of T. annulata interaction with host cells.
METHODS: The transcription level of an SVSP protein from T. annulata, SVSP454, was analyzed between different life stages and transformed cell passages using qRT-PCR. Then, SVSP454 was used as a bait to screen its interacting proteins from the bovine B cell cDNA library using a yeast two-hybrid (Y2H) system. The potential interacting proteins of host cells with SVSP454 were further identified by using a coimmunoprecipitation (Co-IP) and bimolecular fluorescence complementation (BiFC) assays.
RESULTS: SVSP454 was transcribed in all three life stages of T. annulata but had the highest transcription during the schizont stage. However, the transcription level of SVSP454 continuously decreased as the cultures passaged. Two proteins, Bos Taurus coiled-coil domain 181 (CCDC181) and Bos Taurus mitochondrial ribosomal protein L30 (MRPL30), were screened. The proteins CCDC181 and MRPL30 of the host were further identified to directly interact with SVSP454.
CONCLUSION: In the present study, SVSP454 was used as a bait plasmid, and its prey proteins CCDC181 and MRPL30 were screened out by using a Y2H system. Then, we demonstrated that SVSP454 directly interacted with both CCDC181 and MRPL30 by Co-IP and BiFC assays. Therefore, we speculate that SVSP454-CCDC181/SVSP454MRPL30 is an interacting axis that regulates the microtubule network and translation process of the host by some vital signaling molecules. Identification of the interaction of SVSP454 with CCDC181 and MRPL30 will help illustrate the transformation mechanisms induced by T. annulata.

Entities:  

Keywords:  BiFC; CCDC181; Co-IP; MRPL30; SVSP454; Theileria annulata; Yeast two-hybrid

Year:  2021        PMID: 34116718     DOI: 10.1186/s13071-021-04820-4

Source DB:  PubMed          Journal:  Parasit Vectors        ISSN: 1756-3305            Impact factor:   3.876


  28 in total

Review 1.  Theileria-induced leukocyte transformation.

Authors:  Dirk A E Dobbelaere; Sven Rottenberg
Journal:  Curr Opin Microbiol       Date:  2003-08       Impact factor: 7.934

2.  Genome of the host-cell transforming parasite Theileria annulata compared with T. parva.

Authors:  Arnab Pain; Hubert Renauld; Matthew Berriman; Lee Murphy; Corin A Yeats; William Weir; Arnaud Kerhornou; Martin Aslett; Richard Bishop; Christiane Bouchier; Madeleine Cochet; Richard M R Coulson; Ann Cronin; Etienne P de Villiers; Audrey Fraser; Nigel Fosker; Malcolm Gardner; Arlette Goble; Sam Griffiths-Jones; David E Harris; Frank Katzer; Natasha Larke; Angela Lord; Pascal Maser; Sue McKellar; Paul Mooney; Fraser Morton; Vishvanath Nene; Susan O'Neil; Claire Price; Michael A Quail; Ester Rabbinowitsch; Neil D Rawlings; Simon Rutter; David Saunders; Kathy Seeger; Trushar Shah; Robert Squares; Steven Squares; Adrian Tivey; Alan R Walker; John Woodward; Dirk A E Dobbelaere; Gordon Langsley; Marie-Adele Rajandream; Declan McKeever; Brian Shiels; Andrew Tait; Bart Barrell; Neil Hall
Journal:  Science       Date:  2005-07-01       Impact factor: 47.728

Review 3.  Evolution and genetic diversity of Theileria.

Authors:  Thillaiampalam Sivakumar; Kyoko Hayashida; Chihiro Sugimoto; Naoaki Yokoyama
Journal:  Infect Genet Evol       Date:  2014-08-04       Impact factor: 3.342

4.  Theileria annulata and T. parva infect and transform different bovine mononuclear cells.

Authors:  R L Spooner; E A Innes; E J Glass; C G Brown
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

5.  Letter: Infection and transformation of bovine lymphoid cells in vitro by infective particles of Theileria parva.

Authors:  C G Brown; D A Stagg; R E Purnell; G K Kanhai; R C Payne
Journal:  Nature       Date:  1973-09-14       Impact factor: 49.962

Review 6.  Theileria-transformed bovine leukocytes have cancer hallmarks.

Authors:  Kyle Tretina; Hanzel T Gotia; David J Mann; Joana C Silva
Journal:  Trends Parasitol       Date:  2015-05-04

7.  Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3.

Authors:  Julien Guergnon; Frédéric Dessauge; Gordon Langsley; Alphonse Garcia
Journal:  Biochimie       Date:  2003-08       Impact factor: 4.079

8.  Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation.

Authors:  J Marsolier; M Perichon; J D DeBarry; B O Villoutreix; J Chluba; T Lopez; C Garrido; X Z Zhou; K P Lu; L Fritsch; S Ait-Si-Ali; M Mhadhbi; S Medjkane; J B Weitzman
Journal:  Nature       Date:  2015-01-26       Impact factor: 49.962

9.  Secreted parasite Pin1 isomerase stabilizes host PKM2 to reprogram host cell metabolism.

Authors:  Jonathan B Weitzman; Souhila Medjkane; Justine Marsolier; Martine Perichon
Journal:  Commun Biol       Date:  2019-04-30

10.  Intracellular Theileria Parasites PIN Down Host Metabolism.

Authors:  Souhila Medjkane; Jonathan B Weitzman
Journal:  Front Cell Dev Biol       Date:  2020-03-17
View more
  1 in total

1.  Metabolomic profiling of bovine leucocytes transformed by Theileria annulata under BW720c treatment.

Authors:  Hong-Xi Zhao; Xia Li; Jun-Long Liu; Gui-Quan Guan; Xin-Gang Dan
Journal:  Parasit Vectors       Date:  2022-10-05       Impact factor: 4.047

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.